LifeStance Health (LFST) Operating Leases (2022 - 2026)

LifeStance Health (LFST) has 5 years of Operating Leases data on file, last reported at $148.8 million in Q1 2026.

• Operating Leases for Q1 2026 came in at $148.8 million, changed 0.38% year-over-year; the trailing twelve-month figure through Mar 2026 was $148.8 million (changed 0.38% YoY), and the FY2025 annual result was $148.6 million, changed 0.1% from the prior year.
• Operating Leases held at $148.8 million in Q1 2026 per LFST's latest filing, from $148.6 million in the prior quarter.
• Over five years, Operating Leases peaked at $212.6 million in Q4 2022 and troughed at $143.4 million in Q2 2025.
• A 5-year average of $170.0 million and a median of $162.2 million in 2024 frame the typical range for Operating Leases.
• The sharpest annual moves came in 2024 and 2025: Operating Leases decreased 19.38% in 2024, then dropped 0.1% in 2025.
• A 5-year view of Operating Leases shows it stood at $212.6 million in 2022, then dropped by 14.69% to $181.4 million in 2023, then retreated by 18.01% to $148.7 million in 2024, then decreased by 0.1% to $148.6 million in 2025, then advanced by 0.18% to $148.8 million in 2026.
• Business Quant data shows LFST's Operating Leases at $148.8 million in Q1 2026, $148.6 million in Q4 2025, and $144.2 million in Q3 2025.